Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(-)-Eseroline fumarate, a metabolite of the acetylcholinesterase inhibitor Physostigmine, promotes lactic acid dehydrogenase (LDH) leakage from cancer cells and triggers adenine nucleotides and 5-hydroxytryptamine (5-HT) release from neuronal cells, leading to cell death. Additionally, it suppresses electrically evoked muscle contractions in the mouse vas deferens and the guinea-pig ileum.
説明 | (-)-Eseroline fumarate, a metabolite of the acetylcholinesterase inhibitor Physostigmine, promotes lactic acid dehydrogenase (LDH) leakage from cancer cells and triggers adenine nucleotides and 5-hydroxytryptamine (5-HT) release from neuronal cells, leading to cell death. Additionally, it suppresses electrically evoked muscle contractions in the mouse vas deferens and the guinea-pig ileum. |
分子量 | 334.37 |
分子式 | C17H22N2O5 |
CAS No. | 70310-73-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(-)-Eseroline fumarate 70310-73-5 Inhibitor inhibitor inhibit